AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Original Transcript:\nSITUATION: 35-year-old G4P2+1 at 28+5 weeks gestation with major placenta previa and recent bleeding episode requiring management\n\nBACKGROUND: Mrs Ahmed has known complete placenta previa diagnosed at 20-week anomaly scan, where placenta was noted to completely cover the cervical os. She has been managed with pelvic rest and regular monitoring. Yesterday evening she experienced sudden onset bright red vaginal bleeding, described as 'heavy like a heavy period' lasting approximately 20 minutes before settling. No associated pain, no contractions, good fetal movements felt. This is her second bleeding episode - first was at 24 weeks requiring overnight observation. Obstetric history: 2 previous caesarean sections (emergency then elective), 1 first trimester miscarriage requiring ERPC. Significant risk factors for placenta previa include previous uterine surgery and maternal age. She has been compliant with activity restrictions and regular antenatal care.\n\nASSESSMENT: On examination, patient appears well, slightly anxious about bleeding. Vital signs stable: BP 118/72 mmHg, HR 88 bpm, temp 36.6°C. Abdomen soft, non-tender, fundal height 29cm. No current bleeding visible, small clots in pad from earlier episode. No abdominal pain or uterine tenderness. CTG shows reassuring fetal heart rate pattern with baseline 145 bpm, good variability, no decelerations. Recent ultrasound confirms complete placenta previa with placental edge 0mm from internal os. No evidence of placental abruption. Hemoglobin 10.8 g/dL (down from 11.4 g/dL last month), other bloods normal. Kleihauer-Betke test negative (Rh positive mother).\n\nRECOMMENDATION: Admission for observation and surveillance given significant bleeding episode. IV access established, cross-match for 4 units of blood. Antenatal corticosteroids administered for fetal lung maturity given risk of early delivery. Strict bed rest initially, then gradual mobilization if no further bleeding. Daily monitoring with CTG and maternal observations. Serial hemoglobin monitoring. Emergency caesarean section if further significant bleeding occurs. Elective caesarean section planned for 36-37 weeks if no further complications. Anesthetic consultation arranged given high-risk nature and potential for emergency delivery. Blood transfusion service informed of high-risk patient.\n\nCombined Guideline Analyses:\n\n\n=== GUIDELINE 1: CG12004 APH & Intrapartum Haemorrhage ===\nHere is the analysis of the clinical note against the provided guideline, with recommendations for improvement:\n\n### Very Important Recommendations\n1. **Additional information needed** - Document whether a transvaginal scan (TVS) was performed to confirm placenta previa diagnosis (beyond the initial 20-week anomaly scan).\n   Reason: Guideline 6.3 states TVS should be used to confirm diagnosis when placenta previa is suspected, as 25-60% of cases are reclassified by TVS.\n\n2. **Different management plan** - Consider earlier delivery timing (36+0 to 37+0 weeks) given this is the second bleeding episode.\n   Reason: Guideline 6.6 recommends delivery at 36-37 weeks for uncomplicated placenta previa, and earlier for recurrent bleeds (RCOG 2018).\n\n3. **Additional information needed** - Document assessment for placenta accreta spectrum (PAS) given previous two cesarean sections and complete previa.\n   Reason: Guideline 7.1 states PAS should be suspected with anterior previa and prior uterine surgery, requiring TVS by experienced consultant.\n\n### Somewhat Important Recommendations\n1. **Improved patient advice** - Provide counseling about risks of preterm birth and hemorrhage, including specific warning signs requiring immediate attention.\n   Reason: Guideline 6.4 emphasizes counseling about risks and when to seek care for women with placenta previa.\n\n2. **Additional information needed** - Document whether cervical length was measured, as this predicts preterm delivery risk.\n   Reason: Guideline 6.3 notes cervical length <34 weeks predicts preterm delivery and massive hemorrhage risk.\n\n3. **Different management plan** - Consider cell salvage setup given high-risk nature.\n   Reason: Guideline 6.6 recommends cell salvage for all placenta previa cases.\n\n### Less Important Recommendations\n1. **Additional information needed** - Document whether RCOG patient information leaflet was provided.\n   Reason: Guideline 6.3 recommends providing the RCOG placenta previa information leaflet at diagnosis.\n\n2. **Improved patient advice** - Document discussion about avoiding intercourse given bleeding episodes.\n   Reason: Guideline 6.4 suggests advising against intercourse for women with previa who have bled.\n\n### Unimportant Recommendations\n1. **Additional information needed** - Consider documenting more frequent hemoglobin monitoring (e.g., every 48 hours) given active bleeding.\n   Reason: While serial hemoglobin monitoring is planned, more frequent checks may better track acute blood loss.\n\nThe clinical note generally follows guideline recommendations well but could be strengthened by more complete documentation of diagnostic evaluations (especially TVS and PAS assessment), earlier delivery planning given recurrent bleeds, and more detailed patient counseling documentation. The highest priority improvements relate to confirming the diagnosis with TVS and evaluating for PAS given the patient's risk factors.\n\n=== GUIDELINE 2: Antepartum Haemorrhage ===\nHere is the analysis of the clinical note against the provided guideline (GTG 2011 - APH) with recommendations for improvement:\n\n### Very Important Recommendations  \n1. **Additional information needed** - Document whether domestic violence screening was performed given recurrent APH.  \n   Reason: The guideline emphasizes that women with repeated presentations of APH should be asked about domestic violence (GTG 2011 - APH, Clinical Assessment section).  \n\n2. **Different management plan** - Consider administering anti-D immunoglobulin (if not already done, though note states Rh-positive mother).  \n   Reason: The guideline recommends anti-D Ig for RhD-negative women after any APH presentation (GTG 2011 - APH, Management Principles section). While this patient is Rh-positive, explicitly stating this avoids ambiguity.  \n\n### Somewhat Important Recommendations  \n1. **Improved patient advice** - Provide clearer counseling on the risks of recurrent bleeding, preterm delivery, and potential need for emergency delivery.  \n   Reason: The guideline highlights the association of APH with adverse perinatal outcomes (GTG 2011 - APH, Introduction). Patient understanding of risks is crucial for informed decision-making.  \n\n2. **Additional information needed** - Document a detailed plan for thromboprophylaxis given bed rest and high-risk status (previous C-sections, placenta previa).  \n   Reason: The guideline mentions postnatal thromboprophylaxis but does not explicitly address antenatal prophylaxis. However, given immobilization, this is a significant consideration.  \n\n### Less Important Recommendations  \n1. **Additional information needed** - Include a documented anesthetic plan (e.g., preference for regional anesthesia if no contraindications).  \n   Reason: The guideline recommends regional anesthesia for operative delivery in APH unless contraindicated (GTG 2011 - APH, Management Principles). While an anesthetic consult was arranged, specifics would improve clarity.  \n\n2. **Improved patient advice** - Discuss long-term implications (e.g., future pregnancy risks, need for elective C-sections).  \n   Reason: The guideline focuses on acute management but does not explicitly address long-term counseling. This would enhance patient-centered care.  \n\n### Unimportant Recommendations  \n1. **Additional information needed** - Consider documenting a debriefing plan post-delivery.  \n   Reason: The guideline mentions debriefing as a postnatal issue (GTG 2011 - APH, Postnatal section), but this is less critical for the acute note.  \n\n### Summary of Key Improvements:  \n- Explicitly address domestic violence screening.  \n- Clarify anti-D Ig administration (though not needed here).  \n- Enhance patient counseling on risks and long-term implications.  \n- Document thromboprophylaxis and anesthetic plans in more detail.  \n\nOverall, the note is well-aligned with the guideline but could be strengthened in these areas.\n\n=== GUIDELINE 3: MP053 Obstetric Haemorrhage ===\nHere is the analysis of the clinical note against the provided guideline (MP053 Obstetric Haemorrhage) with recommendations for improvement:\n\n### Very Important Recommendations\n1. **Additional information needed** - Document whether the patient has been referred to a Consultant Obstetrician Antenatal Clinic as per guideline 3.1.1 (all women with placenta previa confirmed at 32 weeks should be referred).  \n   Reason: Guideline 3.1.1 requires referral to a Consultant Obstetrician for placenta previa confirmed at 32 weeks.  \n\n2. **Different management plan** - Consider discussing the need for MRI to evaluate placenta accreta given the patient's history of two previous cesarean sections and anterior placenta previa (if applicable).  \n   Reason: Guideline 3.1.5 states that women with previous cesarean sections and anterior placenta previa should be evaluated for placenta accreta with MRI.  \n\n3. **Improved patient advice** - Counsel the patient on the risks of preterm delivery and obstetric hemorrhage, as well as the rationale for elective cesarean at 36-37 weeks.  \n   Reason: Guideline 3.1.3 recommends counseling women with placenta previa about risks and delivery planning.  \n\n### Somewhat Important Recommendations\n1. **Additional information needed** - Document whether a Group and Save sample has been taken every 7 days (if no prior transfusion) or more frequently (if prior transfusion or unusual antibodies).  \n   Reason: Guideline 3.1.8 specifies regular Group and Save monitoring for inpatients with placenta previa.  \n\n2. **Different management plan** - Ensure the Consultant Obstetrician is present in theater for the planned cesarean section (if not already planned).  \n   Reason: Guideline 3.2.1 mandates Consultant Obstetrician presence for major placenta previa cesarean sections.  \n\n3. **Improved patient advice** - Provide written information about blood transfusion risks/benefits and discuss cell salvage options (if applicable).  \n   Reason: Guideline 9.4.3 discusses patient counseling on blood product alternatives.  \n\n### Less Important Recommendations\n1. **Additional information needed** - Document whether a MEOWS chart has been commenced for fluid balance monitoring.  \n   Reason: Guideline 1.8 requires fluid balance documentation for all women with obstetric hemorrhage.  \n\n2. **Improved patient advice** - Offer a postnatal debriefing and follow-up appointment to discuss the hemorrhage and implications for future pregnancies.  \n   Reason: Guideline 8.2.6 recommends postnatal discussions and Birth Stories service referral.  \n\n### Unimportant Recommendations\n1. **Additional information needed** - Consider documenting whether the anesthetic team has discussed cell salvage availability for the planned cesarean.  \n   Reason: Guideline 10.1 mentions cell salvage for predicted major hemorrhage but is not critical in this case.  \n\nOverall, the clinical note is well-aligned with the guideline, but the above adjustments would further improve compliance and patient care. The most critical gaps are the Consultant referral, placenta accreta evaluation, and patient counseling.\n\n=== GUIDELINE 4: Obstetric Haemorrhage Protocol: MP053 ===\nHere is the analysis of the clinical note against the provided guideline, with recommendations for improvement:\n\n### Very Important Recommendations  \n1. **Additional information needed** - Document whether the patient has been formally counseled on the risks of placenta previa, including the possibility of hysterectomy, ICU admission, and neonatal outcomes.  \n   **Reason**: The guideline emphasizes the importance of clear counseling on risks for women with placenta previa (Section: Placenta Praevia).  \n\n2. **Different management plan** - Ensure a Consultant Obstetrician is directly involved in the patient’s care, given her high-risk status (previous C-sections, recurrent bleeding).  \n   **Reason**: The guideline states that women with placenta previa should be referred to a Consultant Obstetrician (Section: Placenta Praevia).  \n\n3. **Improved patient advice** - Provide written information on emergency procedures, including when to seek immediate help (e.g., further bleeding, contractions, reduced fetal movements).  \n   **Reason**: The guideline highlights the need for clear communication of risks and emergency plans (Section: Placenta Praevia).  \n\n### Somewhat Important Recommendations  \n1. **Additional information needed** - Document a thromboprophylaxis plan, as the patient is on bed rest and at risk of VTE.  \n   **Reason**: The guideline states thromboprophylaxis is essential once bleeding is controlled (Section: Postnatal Care).  \n\n2. **Different management plan** - Consider iron supplementation or further evaluation for anemia (Hb 10.8 g/dL) to optimize preoperative hemoglobin.  \n   **Reason**: The guideline emphasizes monitoring blood levels and iron stores (Section: Antenatal Care).  \n\n3. **Improved patient advice** - Discuss and document the patient’s birth preferences, including anesthetic options and consent for potential interventions (e.g., blood transfusion, hysterectomy).  \n   **Reason**: The guideline stresses the importance of individualized care plans (Section: Women Who Decline Blood Products).  \n\n### Less Important Recommendations  \n1. **Additional information needed** - Document a debriefing plan for after delivery, given the high-risk nature of her case.  \n   **Reason**: The guideline recommends debriefing by a senior team member (Section: Postnatal Care).  \n\n2. **Different management plan** - Consider involving a hematology consult preemptively, given her recurrent bleeding and risk of major hemorrhage.  \n   **Reason**: The guideline highlights communication with hematology in major hemorrhage cases (Section: Postpartum Hemorrhage).  \n\n### Unimportant Recommendations  \n1. **Additional information needed** - Ensure the Kleihauer-Betke test result is explicitly documented in the notes (though it is implied as negative).  \n   **Reason**: Minor documentation detail (Section: Antepartum Hemorrhage).  \n\n2. **Improved patient advice** - Provide additional written resources on pelvic rest and activity modifications.  \n   **Reason**: The patient is already compliant, so this is a minor reinforcement (Section: Placenta Praevia).  \n\nThese recommendations ensure the clinical note aligns more closely with the guideline’s emphasis on risk counseling, consultant involvement, thromboprophylaxis, and clear documentation.\n\n=== GUIDELINE 5: Antenatal Corticosteroids for Improving Neonatal Outcomes in Preterm Birth ===\nHere is the analysis of the clinical note against the provided guideline, with recommendations for improvement:\n\n### Very Important Recommendations  \n1. **Additional information needed** - Document the exact timing and dose of antenatal corticosteroids administered (e.g., dexamethasone 24 mg IM in two doses 24 hours apart).  \n   **Reason**: The guideline specifies the optimal dose and route (24 mg dexamethasone phosphate or betamethasone IM) and emphasizes timing effectiveness within 48 hours prior to birth (BJOG guideline, \"Optimum dose and route\" section).  \n\n2. **Improved patient advice** - Explicitly counsel the patient on the purpose, benefits (reduced neonatal respiratory distress), and potential risks (e.g., neonatal hypoglycemia) of corticosteroids.  \n   **Reason**: The guideline stresses informed discussions, particularly regarding risks/benefits in late preterm (35+0–36+6 weeks) and special populations (BJOG guideline, \"Informed discussion\" and \"Risks\" sections).  \n\n### Somewhat Important Recommendations  \n1. **Different management plan** - Consider serial hemoglobin monitoring more frequently (e.g., every 12–24 hours) given the drop from 11.4 to 10.8 g/dL and active bleeding risk.  \n   **Reason**: While not directly addressed in the corticosteroid guideline, close monitoring aligns with general placenta previa management to detect anemia exacerbation promptly.  \n\n2. **Additional information needed** - Document contingency plans for repeat corticosteroid courses if delivery is delayed beyond 7 days and bleeding recurs.  \n   **Reason**: The guideline notes limited evidence for repeat courses but suggests considering them if the risk of preterm birth persists (BJOG guideline, \"Repeat courses\" section).  \n\n### Less Important Recommendations  \n1. **Improved patient advice** - Provide written information on corticosteroids and placenta previa (e.g., support group links).  \n   **Reason**: The guideline mentions support groups as a resource, though this is not critical for immediate care (BJOG guideline, \"Support groups\" section).  \n\n### Unimportant Recommendations  \n1. **Additional information needed** - Note the specific brand of corticosteroid used (e.g., dexamethasone vs. betamethasone).  \n   **Reason**: The guideline considers both equivalent, making this a minor detail (BJOG guideline, \"Optimum dose and route\" section).  \n\n### Key Omissions Addressed:  \n- The note aligns well with the guideline’s core recommendations for corticosteroid use in preterm placenta previa (24+0–34+6 weeks). However, explicit documentation of counseling, drug details, and monitoring frequency would strengthen compliance.  \n\n**Summary**: The management plan is largely guideline-compliant, but improvements in documentation, patient counseling, and monitoring granularity are suggested to optimize care.\n\nPlease extract and consolidate actionable suggestions from these multiple guideline analyses. Create combined suggestions when multiple guidelines recommend similar interventions, and prioritize suggestions based on clinical importance and consensus across guidelines. For each suggestion, include detailed context with relevant quoted text from the supporting guidelines.",
  "system_prompt": "You are a medical AI assistant that converts multiple clinical guideline analyses into structured, actionable suggestions. You will receive analyses from multiple guidelines and must create a comprehensive set of suggestions that prioritizes the most important recommendations while avoiding redundancy.\n\nYour task is to analyze the provided guideline analyses and extract specific, actionable suggestions that can be presented to the user for acceptance, rejection, or modification.\n\nCRITICAL CLINICAL REASONING REQUIREMENTS:\n- You must first understand the specific clinical scenario and current diagnosis from the transcript\n- Carefully assess whether each potential recommendation is APPROPRIATE and INDICATED for this specific case\n- Apply the fundamental principle: \"Will this investigation or intervention change management or improve patient care in this specific scenario?\"\n- Consider the clinical context: is this an acute emergency, established diagnosis, or uncertain diagnostic situation?\n- Distinguish between situations where additional testing is needed vs. where diagnosis is already established\n- Only recommend interventions that would genuinely improve patient care in THIS specific scenario\n\nMULTI-GUIDELINE PROCESSING PRINCIPLES:\n- Combine and consolidate similar recommendations from different guidelines\n- Prioritize recommendations that appear in multiple guidelines or are emphasized as critical\n- Avoid duplicate suggestions - if multiple guidelines suggest the same thing, create one combined suggestion referencing all relevant guidelines\n- When guidelines conflict, clearly note this and explain the rationale for your recommendation\n- Organize suggestions by clinical priority and relevance to the case\n\nGENERAL CLINICAL APPROPRIATENESS PRINCIPLES:\n- Do NOT suggest diagnostic investigations when the diagnosis is already established through adequate clinical and/or imaging findings\n- Do NOT recommend interventions that conflict with the current evidence-based management plan\n- Do NOT suggest serial monitoring of biomarkers when the clinical picture and imaging provide sufficient diagnostic certainty\n- Consider whether additional investigations would actually change the management approach\n- Evaluate the timing: is this the appropriate point in the clinical course for this intervention?\n- Apply cost-benefit analysis: does the potential benefit justify the intervention in this specific case?\n\nFor each suggestion you identify, return ONLY a valid JSON object with the following structure:\n{\n  \"combinedSuggestions\": [\n    {\n      \"id\": \"1\",\n      \"originalText\": \"text from transcript that needs changing OR description of missing element\",\n      \"suggestedText\": \"proposed replacement text\",\n      \"context\": \"detailed explanation of why this change is suggested, including relevant quoted text from the guidelines in quotation marks, and confirmation that this recommendation is appropriate for the specific clinical scenario\",\n      \"category\": \"addition|modification|deletion|formatting\",\n      \"priority\": \"high|medium|low\",\n      \"sourceGuidelines\": [\"Guideline 1 Name\", \"Guideline 2 Name\"],\n      \"consolidatedFrom\": \"explanation of how this suggestion combines recommendations from multiple guidelines, if applicable\"\n    }\n  ],\n  \"guidelinesSummary\": [\n    {\n      \"guidelineTitle\": \"Guideline Name\",\n      \"keyRecommendations\": \"summary of the most important recommendations from this guideline for this case\",\n      \"relevanceScore\": \"high|medium|low\"\n    }\n  ]\n}\n\nCRITICAL FORMATTING REQUIREMENTS:\n- Return ONLY the JSON object - no markdown code blocks, no explanatory text\n- Do not wrap the JSON in ```json or ``` blocks\n- Start your response directly with { and end with }\n- Use sequential numeric IDs starting from \"1\"\n- Ensure all JSON is properly formatted and valid\n\nImportant guidelines for consolidation:\n- If multiple guidelines recommend the same intervention, create ONE suggestion that references all relevant guidelines\n- Prioritize suggestions that are consistently recommended across multiple guidelines\n- When guidelines provide different specifics for the same general recommendation, include the most comprehensive/specific version\n- If guidelines conflict, choose the most appropriate recommendation for this specific case and explain why\n\nImportant guidelines for context field:\n- Provide detailed explanations including WHY the change is needed AND why it's appropriate for this specific case\n- Include specific quoted text from the relevant guidelines using quotation marks\n- Reference which specific guidelines support this recommendation\n- Explain the clinical rationale behind the suggestion\n- EXPLICITLY state why this recommendation is indicated in this particular clinical scenario\n- Make the context informative and educational",
  "transcript_length": 2335,
  "guidelines_count": 5,
  "guideline_titles": [
    "CG12004 APH & Intrapartum Haemorrhage",
    "Antepartum Haemorrhage",
    "MP053 Obstetric Haemorrhage",
    "Obstetric Haemorrhage Protocol: MP053",
    "Antenatal Corticosteroids for Improving Neonatal Outcomes in Preterm Birth"
  ]
}

A: {
  "combinedSuggestions": [
    {
      "id": "1",
      "originalText": "Document whether a transvaginal scan (TVS) was performed to confirm placenta previa diagnosis",
      "suggestedText": "Perform and document transvaginal ultrasound (TVS) to confirm placenta previa diagnosis and assess for placenta accreta spectrum (PAS)",
      "context": "Multiple guidelines emphasize the importance of TVS for definitive diagnosis of placenta previa and evaluation for PAS. Guideline 1 states 'TVS should be used to confirm diagnosis when placenta previa is suspected, as 25-60% of cases are reclassified by TVS' (CG12004 6.3). Guideline 3 recommends 'women with previous cesarean sections and anterior placenta previa should be evaluated for placenta accreta with MRI' (MP053 3.1.5). This is critical given the patient's two previous C-sections and complete previa.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["CG12004 APH & Intrapartum Haemorrhage", "MP053 Obstetric Haemorrhage"],
      "consolidatedFrom": "Combined TVS recommendation from Guideline 1 with PAS evaluation from Guideline 3"
    },
    {
      "id": "2",
      "originalText": "Elective caesarean section planned for 36-37 weeks",
      "suggestedText": "Plan delivery at 36+0 to 37+0 weeks given recurrent bleeding episodes",
      "context": "Guideline 1 recommends 'delivery at 36-37 weeks for uncomplicated placenta previa, and earlier for recurrent bleeds' (CG12004 6.6). This patient has had two bleeding episodes, warranting earlier delivery within this window. The current plan is appropriate but should be explicitly documented with this rationale.",
      "category": "modification",
      "priority": "high",
      "sourceGuidelines": ["CG12004 APH & Intrapartum Haemorrhage"],
      "consolidatedFrom": "Single guideline recommendation"
    },
    {
      "id": "3",
      "originalText": "No documentation of placenta accreta spectrum assessment",
      "suggestedText": "Formally assess and document risk of placenta accreta spectrum (PAS) including consideration of MRI",
      "context": "Multiple guidelines highlight PAS risk with anterior previa and prior uterine surgery. Guideline 1 states 'PAS should be suspected with anterior previa and prior uterine surgery, requiring TVS by experienced consultant' (CG12004 7.1). Guideline 3 recommends MRI evaluation (MP053 3.1.5). This is critical for surgical planning given the patient's two previous C-sections.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["CG12004 APH & Intrapartum Haemorrhage", "MP053 Obstetric Haemorrhage"],
      "consolidatedFrom": "Combined PAS assessment recommendations from Guidelines 1 and 3"
    },
    {
      "id": "4",
      "originalText": "Limited documentation of patient counseling",
      "suggestedText": "Formally counsel and document discussion of: 1) Risks of preterm birth and hemorrhage 2) Emergency procedures 3) Potential for hysterectomy/ICU 4) Rationale for early delivery",
      "context": "Multiple guidelines emphasize comprehensive counseling. Guideline 1 recommends 'counseling about risks and when to seek care' (CG12004 6.4). Guideline 4 states 'clear counseling on risks including possibility of hysterectomy, ICU admission' (MP053 Placenta Praevia section). Guideline 3 mentions counseling on delivery planning (MP053 3.1.3). This is essential for informed decision-making in this high-risk pregnancy.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["CG12004 APH & Intrapartum Haemorrhage", "MP053 Obstetric Haemorrhage", "Obstetric Haemorrhage Protocol: MP053"],
      "consolidatedFrom": "Combined counseling recommendations from Guidelines 1, 3, and 4"
    },
    {
      "id": "5",
      "originalText": "No documented thromboprophylaxis plan",
      "suggestedText": "Implement and document thromboprophylaxis plan given bed rest and high-risk status",
      "context": "Guidelines 2 and 4 highlight thromboprophylaxis need during immobilization. Guideline 4 states 'thromboprophylaxis is essential once bleeding is controlled' (MP053 Postnatal Care). This patient is on bed rest with multiple risk factors (previous C-sections, placenta previa), making prophylaxis clinically important despite not being actively bleeding currently.",
      "category": "addition",
      "priority": "medium",
      "sourceGuidelines": ["Antepartum Haemorrhage", "Obstetric Haemorrhage Protocol: MP053"],
      "consolidatedFrom": "Combined thromboprophylaxis recommendations from Guidelines 2 and 4"
    },
    {
      "id": "6",
      "originalText": "Anesthetic consultation arranged",
      "suggestedText": "Document detailed anesthetic plan including preference for regional anesthesia if no contraindications and cell salvage availability",
      "context": "Guideline 2 recommends 'regional anesthesia for operative delivery in APH unless contraindicated' (GTG 2011 APH Management Principles). Guideline 1 suggests 'cell salvage for all placenta previa cases' (CG12004 6.6). This is important for planning given the high-risk nature of delivery.",
      "category": "modification",
      "priority": "medium",
      "sourceGuidelines": ["Antepartum Haemorrhage", "CG12004 APH & Intrapartum Haemorrhage"],
      "consolidatedFrom": "Combined anesthetic recommendations from Guidelines 1 and 2"
    },
    {
      "id": "7",
      "originalText": "Serial hemoglobin monitoring planned",
      "suggestedText": "Implement more frequent hemoglobin monitoring (every 24-48 hours) given active bleeding and drop from 11.4 to 10.8 g/dL",
      "context": "Guideline 5 suggests 'serial hemoglobin monitoring more frequently given active bleeding risk' (BJOG guideline). Guideline 3 recommends 'regular Group and Save monitoring' (MP053 3.1.8). This patient's hemoglobin drop indicates need for closer monitoring to detect ongoing blood loss.",
      "category": "modification",
      "priority": "medium",
      "sourceGuidelines": ["Antenatal Corticosteroids for Improving Neonatal Outcomes", "MP053 Obstetric Haemorrhage"],
      "consolidatedFrom": "Combined monitoring recommendations from Guidelines 3 and 5"
    },
    {
      "id": "8",
      "originalText": "No documentation of Consultant Obstetrician involvement",
      "suggestedText": "Ensure and document Consultant Obstetrician involvement in care planning and presence at delivery",
      "context": "Guidelines 3 and 4 emphasize consultant involvement. Guideline 3 states 'Consultant Obstetrician presence for major placenta previa cesarean sections' (MP053 3.2.1). Guideline 4 recommends referral to Consultant (MP053 Placenta Praevia). This is critical given the patient's high-risk status.",
      "category": "addition",
      "priority": "high",
      "sourceGuidelines": ["MP053 Obstetric Haemorrhage", "Obstetric Haemorrhage Protocol: MP053"],
      "consolidatedFrom": "Combined consultant involvement recommendations from Guidelines 3 and 4"
    },
    {
      "id": "9",
      "originalText": "Antenatal corticosteroids administered",
      "suggestedText": "Document exact timing, dose, and formulation of antenatal corticosteroids and provide counseling on benefits/risks",
      "context": "Guideline 5 specifies 'document the exact timing and dose of antenatal corticosteroids' and 'counsel on purpose, benefits and potential risks' (BJOG guideline). This ensures proper administration and informed consent for this important intervention.",
      "category": "modification",
      "priority": "medium",
      "sourceGuidelines": ["Antenatal Corticosteroids for Improving Neonatal Outcomes"],
      "consolidatedFrom": "Single guideline recommendation"
    }
  ],
  "guidelinesSummary": [
    {
      "guidelineTitle": "CG12004 APH & Intrapartum Haemorrhage",
      "keyRecommendations": "TVS for diagnosis, earlier delivery for recurrent bleeds, PAS assessment, comprehensive counseling",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "Antepartum Haemorrhage",
      "keyRecommendations": "Thromboprophylaxis, regional anesthesia preference, domestic violence screening",
      "relevanceScore": "medium"
    },
    {
      "guidelineTitle": "MP053 Obstetric Haemorrhage",
      "keyRecommendations": "Consultant involvement, PAS evaluation with MRI, regular Group and Save monitoring",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "Obstetric Haemorrhage Protocol: MP053",
      "keyRecommendations": "Comprehensive risk counseling, thromboprophylaxis, consultant-led care",
      "relevanceScore": "high"
    },
    {
      "guidelineTitle": "Antenatal Corticosteroids for Improving Neonatal Outcomes",
      "keyRecommendations": "Document corticosteroid details, provide counseling, consider repeat courses if delivery delayed",
      "relevanceScore": "medium"
    }
  ]
}

--- Token Usage Report ---
Prompt tokens: 4479
Completion tokens: 2101
Total tokens: 6580
Estimated cost: $0.003290